Log in

NASDAQ:FONRFonar Stock Price, Forecast & News

$20.90
-0.17 (-0.81 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$20.76
Now: $20.90
$21.41
50-Day Range
$19.50
MA: $22.94
$25.49
52-Week Range
$11.00
Now: $20.90
$25.99
Volume34,382 shs
Average Volume89,159 shs
Market Capitalization$134.81 million
P/E Ratio11.94
Dividend YieldN/A
Beta1.09
FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.01 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FONR
CUSIPN/A
Phone631-694-2929

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$87.19 million
Cash Flow$2.86 per share
Book Value$18.58 per share

Profitability

Net Income$15.32 million

Miscellaneous

EmployeesN/A
Market Cap$134.81 million
Next Earnings Date9/11/2020 (Estimated)
OptionableNot Optionable

Receive FONR News and Ratings via Email

Sign-up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.

Fonar (NASDAQ:FONR) Frequently Asked Questions

How has Fonar's stock been impacted by COVID-19 (Coronavirus)?

Fonar's stock was trading at $15.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FONR shares have increased by 37.5% and is now trading at $20.90. View which stocks have been most impacted by Coronavirus.

When is Fonar's next earnings date?

Fonar is scheduled to release its next quarterly earnings announcement on Friday, September 11th 2020. View our earnings forecast for Fonar.

How were Fonar's earnings last quarter?

Fonar Co. (NASDAQ:FONR) announced its earnings results on Monday, May, 11th. The medical equipment provider reported $0.18 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $21.69 million for the quarter. Fonar had a return on equity of 9.35% and a net margin of 13.16%. View Fonar's earnings history.

Has Fonar been receiving favorable news coverage?

Media headlines about FONR stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fonar earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the near future. View the latest news about Fonar.

Are investors shorting Fonar?

Fonar saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 78,300 shares, an increase of 77.1% from the May 31st total of 44,200 shares. Based on an average daily volume of 40,200 shares, the short-interest ratio is currently 1.9 days. Currently, 1.3% of the company's stock are sold short. View Fonar's Current Options Chain.

Who are some of Fonar's key competitors?

What other stocks do shareholders of Fonar own?

Who are Fonar's key executives?

Fonar's management team includes the following people:
  • Dr. Raymond V. Damadian, Chairman, Principal Financial Officer & Treasurer (Age 83)
  • Mr. Timothy R. Damadian, CEO & Pres (Age 55)
  • Mr. Luciano B. Bonanni, COO & Exec. VP (Age 64)
  • Ms. Claudette J. V. Chan, Sec. & Director (Age 81)
  • Mr. Daniel Culver, Director of Communications

What is Fonar's stock symbol?

Fonar trades on the NASDAQ under the ticker symbol "FONR."

How do I buy shares of Fonar?

Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fonar's stock price today?

One share of FONR stock can currently be purchased for approximately $20.90.

How big of a company is Fonar?

Fonar has a market capitalization of $134.81 million and generates $87.19 million in revenue each year.

What is Fonar's official website?

The official website for Fonar is www.fonar.com.

How can I contact Fonar?

Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.